Loading…

Celer Biotecnologia inaugurated a new factory in Montes Claros, Minas Gerais, with an initial investment of R$20 million. The plant will expand production of rapid diagnostic tests for the point-of-care segment. An additional R$50 million will be invested over the next two years, and up to R$100 million over five years. The factory is expected to generate up to 130 direct jobs in three years.
“A Celer Biotecnologia – empresa mineira que atua no segmento de diagnóstico clínico humano e veterinário – acaba de inaugurar sua nova fábrica em Montes Claros, Norte de Minas.”newslab.com.br
Summarized from public sources; check the original articles before acting on it.